Funding for this research was provided by:
National Institutes of Health (R01 EB030987, AR076820, AR073752, R01 CA171651, S10 OD027042, R01 CA260855)
VA Merit Review (I01 BX005075)
Received: 2 June 2021
Accepted: 4 October 2021
First Online: 25 October 2021
: All animal experiments were performed in compliance with guidelines and protocols approved by the Division of Comparative Medicine at Washington University in St. Louis. The animal protocol is subjected to annual review and approval by The Animal Studies Committee of Washington University.
: Not applicable.
: The authors declare that they have no competing interests, except that SA is a co-inventor on a US patent issued to Washington University covering LS301, which has been licensed for cancer imaging. The patent may become the subject of a licensing agreement in the future.